Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$991M |
| 2 |
Broadcom
AVGO
|
+$941M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$859M |
| 4 |
Amazon
AMZN
|
+$858M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$425M |
| 2 |
Merck
MRK
|
+$379M |
| 3 |
ASML
ASML
|
+$336M |
| 4 |
Yum China
YUMC
|
+$311M |
| 5 |
Microchip Technology
MCHP
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Financials | 12.43% |
| 3 | Industrials | 11.73% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Westrock Coffee
WEST
$798M
| $93.5K | ﹤0.01% |
14,378
+187
| +1% | +$1.64K |
|
3527
Pulmonx
LUNG
$52.8M
| $92.7K | ﹤0.01% |
11,188
+655
| +6% | +$4.74K |
|
3528
CBAK Energy Technology Ltd
CBAT
$43.1M
| $92.1K | ﹤0.01% |
+73,689
| New | +$82.7K |
|
3529
TScan Therapeutics
TCRX
$48.5M
| $89.7K | ﹤0.01% |
18,016
-481,858
| -96% | -$2.91M |
|
3530
Larimar Therapeutics
LRMR
$377M
| $88.2K | ﹤0.01% |
13,467
-427,820
| -97% | -$3.44M |
|
3531
Telos
TLS
$331M
| $87.6K | ﹤0.01% |
24,398
-18,904
| -44% | -$67.6K |
|
|
TTSH
3532
DELISTED
Tile Shop Holdings
TTSH
| $87.2K | ﹤0.01% |
13,230
-52,754
| -80% | -$343K |
|
3533
Sutro Biopharma
STRO
$386M
| $86.9K | ﹤0.01% |
2,513
-113
| -4% | -$4.43K |
|
3534
Nano X Imaging
NNOX
$61.1M
| $86.8K | ﹤0.01% |
14,280
+227
| +2% | +$1.61K |
|
|
CTEV
3535
Claritev Corp
CTEV
$399M
| $86.3K | ﹤0.01% |
11,299
-166
| -1% | -$1.95K |
|
3536
Treace Medical Concepts
TMCI
$262M
| $85.3K | ﹤0.01% |
14,713
+267
| +2% | +$1.72K |
|
3537
Atossa Therapeutics
ATOS
$23M
| $85.2K | ﹤0.01% |
3,735
-125
| -3% | -$2.52K |
|
3538
LifeMD
LFMD
$176M
| $85K | ﹤0.01% |
16,216
-15,187
| -48% | -$87.6K |
|
|
NXDT
3539
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $84.8K | ﹤0.01% |
13,561
+55
| +0.4% | +$326 |
|
|
CTV
3540
DELISTED
Innovid Corp.
CTV
| $84.3K | ﹤0.01% |
46,852
-44,889
| -49% | -$81.5K |
|
3541
Vivid Seats
SEAT
$81.6M
| $83K | ﹤0.01% |
1,121
-4,423
| -80% | -$403K |
|
3542
X4 Pharmaceuticals
XFOR
$377M
| $82.8K | ﹤0.01% |
4,126
+840
| +26% | +$17.5K |
|
|
PSTX
3543
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $82.6K | ﹤0.01% |
28,865
-824
| -3% | -$2.55K |
|
|
INZY
3544
DELISTED
Inozyme Pharma
INZY
| $80.7K | ﹤0.01% |
15,423
-981
| -6% | -$5.09K |
|
3545
Domo
DOMO
$171M
| $79.7K | ﹤0.01% |
10,611
-10,038
| -49% | -$76.6K |
|
3546
Melco Resorts & Entertainment
MLCO
$2.21B
| $78.2K | ﹤0.01% |
10,038
-2,094
| -17% | -$12.4K |
|
3547
Pyxis Oncology
PYXS
$185M
| $77.7K | ﹤0.01% |
21,175
-928
| -4% | -$3.25K |
|
3548
Achieve Life Sciences
ACHV
$633M
| $76.2K | ﹤0.01% |
16,073
-141
| -0.9% | -$644 |
|
3549
Black Diamond Therapeutics
BDTX
$95.1M
| $76K | ﹤0.01% |
17,480
-694,902
| -98% | -$3.78M |
|
3550
Lucas GC Ltd
LGCL
$59.9M
| $73.4K | ﹤0.01% |
+1,624
| New | +$115K |
|
Similar funds
Invesco's Q3 2024 Portfolio in Review
As of Q3 2024, Invesco held 3,952 positions worth $518B, up 9.5% from $473B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q3 2024 filing shows 81 new, 1,757 increased, 1,790 reduced and 200 closed positions. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M. The largest sale was Advanced Micro Devices, an estimated $425M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q3 2024 buy was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M.
- Invesco added most to Apple in Q3 2024, an estimated $991M increase.
- Invesco's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $425M.
- Invesco fully exited WestRock Company in Q3 2024, selling an estimated $196M.
- Invesco's ten largest holdings make up 18% of its $518B portfolio in Q3 2024.
- Invesco opened 81 new positions and closed 200 in Q3 2024.
- Invesco's portfolio value rose 9.5% quarter-over-quarter to $518B.
Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.